查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1772514

美國生物處理容器市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、細分市場預測，2025-2033 年

U.S. Bioprocess Containers Market Size, Share & Trends Analysis Report By Product (2D U.S. Bioprocess Containers, 3D U.S. Bioprocess Containers), By Application (Upstream Process, Downstream Process), By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國生物處理容器市場摘要

美國生物處理容器市場規模預計在 2024 年為 10.9 億美元，預計到 2033 年將達到 65.5 億美元，2025 年至 2033 年的複合年成長率為 22.1%。該行業的發展受到生物製藥製造中一次性技術的日益普及以及對生技藥品和疫苗生產靈活、可擴展解決方案的需求不斷成長的推動。

此外，強勁的研發投入和支持性法律規範將進一步推動市場成長。生物製藥產業的快速成長是市場成長的主要驅動力，尤其是對單株抗體、細胞和基因療法以及疫苗日益成長的需求。一次性生物製程容器 (SUBC) 是現代生物製造的理想選擇，因為它們靈活、經濟高效，並且與傳統不銹鋼系統相比，污染風險更低。例如，在新冠疫情期間，mRNA 疫苗生產的激增凸顯了對可擴展、一次性解決方案的需求，輝瑞和 Moderna 等公司嚴重依賴一次性技術來加快生產進度。

另一個關鍵促進因素是向個人化醫療和小批量生產的轉變，這有利於一次性系統，因為它們具有適應性強且營運成本低。細胞和基因療法（例如CAR-T細胞療法）需要專門的無菌環境，而SUBC無需經過大量清洗和驗證即可實現。賽默飛世爾科技和賽多利斯等公司正在擴展其可客製化生物處理容器產品組合，以用於這些先進療法。此外，美國食品藥物管理局（FDA）等機構鼓勵生物製造創新的監管支持也進一步推動了市場的成長。

此外，永續性和業務效率正在推動其應用，因為與傳統系統相比，一次性容器可以減少水和能源消耗。製藥公司面臨最大程度減少環境足跡的壓力，而SUBC透過消除清洗和滅菌的需求，有助於實現這一目標。隨著生物製藥管道的擴展以及製造商對靈活性的重視，在技術進步和不斷變化的行業需求的支持下，美國生物處理容器市場預計將穩步成長。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國生物處理容器市場變數、趨勢與範圍

  • 市場展望
  • 滲透和成長前景圖
  • 產業價值鏈分析
    • 原料趨勢
    • 製造/技術趨勢
  • 法律規範
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 商業環境分析
    • 波特五力分析
    • PESTEL分析

第4章美國生物加工容器市場：按產品分類的估計和趨勢分析

  • 關鍵要點
  • 2024 年和 2033 年產品特定變化分析和市場佔有率
    • 2D生物製程容器
    • 3D生物處理容器
    • 其他容器及配件

第5章美國生物處理容器市場：按應用的估計和趨勢分析

  • 關鍵要點
  • 2024 年及 2033 年各應用領域的趨勢分析及市場佔有率
    • 上游流程
    • 下游工藝
    • 製程開發

第6章美國生物加工容器市場：按最終用途的估計和趨勢分析

  • 關鍵要點
  • 2024 年和 2033 年按最終用途分類的趨勢分析和市場佔有率
    • 製藥和生物製藥公司
    • 委外研發機構和業務製造組織
    • 學術研究所
    • 其他

第7章 競爭態勢

  • 主要企業、最新發展及其對該產業的影響
  • 公司分類
  • 企業市場分析
  • 公司熱圖分析
  • 企業儀錶板分析
  • 戰略地圖
    • 擴張
    • 合併與收購
    • 合作
    • 新用途公告
    • 其他

第8章 公司列表（公司概況、財務表現、應用概述）

  • Thermo Fisher Scientific Inc.
    • 公司簡介
    • 財務表現
    • 應用程式基準
  • Merck
  • Saint-Gobain
  • Parker Hannifin Corp
  • Kiefel
  • Sartorius AG
  • CellBios
  • Entegris
  • Liquidyne Process Technologies, Inc.
  • Vonco Products, LLC
  • Anlagenbau GmbH
  • Avantor, Inc.
  • ILC Dover
Product Code: GVR-4-68040-635-4

U.S. Bioprocess Containers Market Summary

The U.S. bioprocess containers market size was estimated at USD 1.09 billion in 2024, and is projected to reach USD 6.55 billion by 2033, growing at a CAGR of 22.1% from 2025 to 2033. The industry is driven by the increasing adoption of single-use technologies in biopharmaceutical manufacturing and the growing demand for flexible, scalable solutions for biologics and vaccine production.

Additionally, strong R&D investments and supportive regulatory frameworks further accelerate market growth.The market is primarily driven by the rapid growth of the biopharmaceutical industry, particularly the increasing demand for monoclonal antibodies, cell and gene therapies, and vaccines. Single-use bioprocess containers (SUBCs) offer flexibility, cost-efficiency, and reduced contamination risks compared to traditional stainless-steel systems, making them ideal for modern biomanufacturing. For example, the surge in mRNA vaccine production during the COVID-19 pandemic highlighted the need for scalable, disposable solutions, with companies such as Pfizer and Moderna relying heavily on single-use technologies to accelerate production timelines.

Another key factor is the shift toward personalized medicine and small-batch production, which favors single-use systems due to their adaptability and lower operational costs. Cell and gene therapies, such as CAR-T cell treatments, require specialized, sterile environments that SUBCs can provide without extensive cleaning or validation. Companies such as Thermo Fisher Scientific Inc. and Sartorius AG have expanded their portfolios to include customizable bioprocess containers tailored for these advanced therapies. Additionally, regulatory support from agencies such as the FDA, which encourages innovation in biomanufacturing, further propels market growth.

Moreover, sustainability and operational efficiency are driving adoption, as single-use containers reduce water and energy consumption compared to traditional systems. Pharmaceutical companies are under pressure to minimize their environmental footprint, and SUBCs help achieve this by eliminating the need for cleaning and sterilization. As biopharmaceutical pipelines expand and manufacturers prioritize agility, the U.S. bioprocess containers market is expected to grow steadily, supported by technological advancements and evolving industry needs.

U.S. Bioprocess Containers Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. bioprocess containers market report based on product type, application, and end use:

  • Product Type Outlook (Revenue, USD Million, 2021 - 2033)
  • 2D U.S. Bioprocess Containers
  • 3D U.S. Bioprocess Containers
  • Other Containers & Accessories
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Upstream Processes
  • Downstream Processes
  • Process Developments
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Research Organizations & Contract Manufacturing Organizations
  • Academic & Research Institutes
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
    • 1.1.1. Market Segmentation
    • 1.1.2. Market Definition
  • 1.2. Research Scope & Assumptions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot, 2024 (USD Million)
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Bioprocess Containers Market Variables, Trends, and Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Raw Material Trends
    • 3.3.2. Manufacturing/Technology Trends
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Driver Analysis
    • 3.5.2. Market Restraint Analysis
    • 3.5.3. Market Opportunity Analysis
    • 3.5.4. Market Challenge Analysis
  • 3.6. Business Environment Analysis
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL Analysis

Chapter 4. U.S. Bioprocess Containers Market: Product Type Estimates & Trend Analysis

  • 4.1. Key Takeaways
  • 4.2. Product Type Movement Analysis & Market Share, 2024 & 2033
    • 4.2.1. 2D Bioprocess Containers
      • 4.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.2.2. 3D Bioprocess Containers
      • 4.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.2.3. Other Containers & Accessories
      • 4.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Bioprocess Containers Market: Application Estimates & Trend Analysis

  • 5.1. Key Takeaways
  • 5.2. Application Movement Analysis & Market Share, 2024 & 2033
    • 5.2.1. Upstream Processes
      • 5.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.2.2. Downstream Processes
      • 5.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.2.3. Process Developments
      • 5.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Bioprocess Containers Market: End Use Estimates & Trend Analysis

  • 6.1. Key Takeaways
  • 6.2. End Use Movement Analysis & Market Share, 2024 & 2033
    • 6.2.1. Pharmaceutical & Biopharmaceutical Companies
      • 6.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. Contract Research Organizations & Contract Manufacturing Organizations
      • 6.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Academic & Research Institutes
      • 6.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Others
      • 6.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Key Players & Recent Developments & Their Impact on the Industry
  • 7.2. Company Categorization
  • 7.3. Company Market Position Analysis
  • 7.4. Company Heat Map Analysis
  • 7.5. Company Dashboard Analysis
  • 7.6. Strategy Mapping
    • 7.6.1. Expansions
    • 7.6.2. Mergers & Acquisitions
    • 7.6.3. Collaborations
    • 7.6.4. New Application Launches
    • 7.6.5. Others

Chapter 8. Company Listing (Overview, Financial Performance, Applications Overview)

  • 8.1. Thermo Fisher Scientific Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Application Benchmarking
  • 8.2. Merck
  • 8.3. Saint-Gobain
  • 8.4. Parker Hannifin Corp
  • 8.5. Kiefel
  • 8.6. Sartorius AG
  • 8.7. CellBios
  • 8.8. Entegris
  • 8.9. Liquidyne Process Technologies, Inc.
  • 8.10. Vonco Products, LLC
  • 8.11. Anlagenbau GmbH
  • 8.12. Avantor, Inc.
  • 8.13. ILC Dover

List of Tables

  • 1. U.S. Bioprocess Containers market estimates and forecasts, by Product Type, 2021 - 2033 (USD Million)
  • 2. U.S. Bioprocess Containers market estimates and forecasts, by 2D Bioprocess Containers, 2021 - 2033 (USD Million)
  • 3. U.S. Bioprocess Containers market estimates and forecasts, by 3D Bioprocess Containers, 2021 - 2033 (USD Million)
  • 4. U.S. Bioprocess Containers market estimates and forecasts, by Other Containers & Accessories, 2021 - 2033 (USD Million)
  • 5. U.S. Bioprocess Containers market estimates and forecasts, by Application, 2021 - 2033 (USD Million)
  • 6. U.S. Bioprocess Containers market estimates and forecasts, by Upstream Processes, 2021 - 2033 (USD Million)
  • 7. U.S. Bioprocess Containers market estimates and forecasts, by Downstream Processes, 2021 - 2033 (USD Million)
  • 8. U.S. Bioprocess Containers market estimates and forecasts, by Process Developments, 2021 - 2033 (USD Million)
  • 9. U.S. Bioprocess Containers market estimates and forecasts, by End Use, 2021 - 2033 (USD Million)
  • 10. U.S. Bioprocess Containers market estimates and forecasts, in Pharmaceutical & Biopharmaceutical Companies, 2021 - 2033 (USD Million)
  • 11. U.S. Bioprocess Containers market estimates and forecasts, in Contract Research Organizations & Contract Manufacturing Organizations, 2021 - 2033 (USD Million)
  • 12. U.S. Bioprocess Containers market estimates and forecasts, in Academic & Research Institutes, 2021 - 2033 (USD Million)
  • 13. U.S. Bioprocess Containers market estimates and forecasts, in Others, 2021 - 2033 (USD Million)

List of Figures

  • 1. Information Procurement
  • 2. Primary Research Pattern
  • 3. Primary Research Process
  • 4. Market Research Approaches - Bottom-Up Approach
  • 5. Market Research Approaches - Top-Down Approach
  • 6. Market Research Approaches - Combined Approach
  • 7. U.S. Bioprocess Containers Market- Market Snapshot
  • 8. U.S. Bioprocess Containers Market- Segment Snapshot (1/2)
  • 9. U.S. Bioprocess Containers Market- Segment Snapshot (2/2)
  • 10. U.S. Bioprocess Containers Market- Competitive Landscape Snapshot
  • 11. U.S. Bioprocess Containers Market: Penetration & Growth Prospect Mapping
  • 12. U.S. Bioprocess Containers Market: Value Chain Analysis
  • 13. U.S. Bioprocess Containers Market: Porter's Five Force Analysis
  • 14. U.S. Bioprocess Containers Market: PESTEL Analysis
  • 15. U.S. Bioprocess Containers Market: Product Type Movement Analysis, 2024 & 2033
  • 16. U.S. Bioprocess Containers Market: Application Movement Analysis, 2024 & 2033
  • 17. U.S. Bioprocess Containers Market: End Use Movement Analysis, 2024 & 2033
  • 18. U.S. Bioprocess Containers Market: Company Positioning Analysis
  • 19. U.S. Bioprocess Containers Market: Market Dashboard Analysis